Open AccessJournal Article
Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
Reads0
Chats0
TLDR
These experiments demonstrate that vaccine-induced immunity against cutaneous leishmaniasis is strongly associated with the induction of cell-mediated immunity, but does not require the development of an antibody response to promastigote surface antigens.Abstract:
BALB/c mice can be protected against a fatal Leishmania major infection by immunization with whole radio-attenuated promastigotes; however, neither the antigens responsible for protection nor the protective immunologic mechanisms have been defined. In this study, the ability of promastigote fractions to elicit similar immunity to that obtained with whole organisms, and the immune responses associated with such protection were analyzed. Intraperitoneal immunization with a soluble, membrane-free parasite extract was found to induce protection against L. major challenge equal to that obtained with whole organisms. Induction of immunity (89% protection in seven experiments) was most effective with 100 micrograms of the soluble leishmanial antigen (SLA) and required concomitant injection of the bacterial adjuvant, Corynebacterium parvum (CP), followed by an i.p. boost of SLA alone 1 wk later. Vaccinated animals exhibited Leishmania-specific cell-mediated immunity, as assessed both by lymphocyte transformation and the production of macrophage-activating factors (MAF). In addition, although SLA + CP-immunized mice failed to exhibit delayed-type hypersensitivity (DTH) before challenge, splenic lymphocytes from these mice could transfer a local DTH reaction to naive recipients. Immunization also induced the production of antibodies against two major metabolically labeled proteins of m.w. 30,000 and 53,000, but failed to stimulate a detectable humoral response against promastigote surface antigens. Thus, these experiments demonstrate that vaccine-induced immunity against cutaneous leishmaniasis is strongly associated with the induction of cell-mediated immunity, but does not require the development of an antibody response to promastigote surface antigens. In addition, these studies establish the feasibility of employing soluble, nonmembrane-derived parasite material as a source of protective immunogens.read more
Citations
More filters
Journal ArticleDOI
Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.
TL;DR: It is demonstrated that a T cell line established against fraction 9, designated line 9, transfers protection equivalent to that obtained by active immunization, and suggested that susceptibility and resistance in experimental leishmaniasis may depend upon a balance between the Th subsets induced.
Journal ArticleDOI
The adjuvant effect of interleukin-12 in a vaccine against Leishmania major
Luís Carlos Crocco Afonso,Tanya M. Scharton,Leda Quercia Vieira,Maria Wysocka,Giorgio Trinchieri,Phillip Scott +5 more
TL;DR: IL-12 is an effective adjuvant for the initiation of protective cell- mediated immunity against leishmaniasis and may be an important component in other vaccines that need to induce cell-mediated immunity.
Journal Article
CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.
Stefan Zimmermann,Oliver Egeter,Susanne Hausmann,Grayson B. Lipford,Martin Röcken,Hermann Wagner,Klaus Heeg +6 more
TL;DR: Findings imply an important role of bacterial DNA and CpG-ODN in the instruction of adaptive immune responses and point to the therapeutic potential of C pG- ODN in redirecting curative Th1 responses in Th2-driven disorders.
Journal ArticleDOI
Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease
TL;DR: It is shown that ablation of schistosome-induced eosinophilia by in vivo anti-IL-5 monoclonal treatment fails to reduce the protection induced by irradiated cercariae.
Journal ArticleDOI
Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites
TL;DR: It is demonstrated that although effector CD4+ T cells are lost in the absence of parasites, central memory CD4-T cells are maintained and suggest that central memory T cells should be the targets for nonlive vaccines against infectious diseases requiring cell-mediated immunity.